Success Metrics

Clinical Success Rate

33.3%

Based on 1 completed trials

Completion Rate

33%(1/3)

Active Trials

1(25%)

Results Posted

100%(1 trials)

Terminated

2(50%)

Phase Distribution

Ph not_applicable

25%

Ph phase_1

25%

Ph phase_2

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

1(33.3%)

Phase 2Efficacy & side effects

1(33.3%)

N/ANon-phased studies

1(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

33.3%

1 of 3 finished

Non-Completion Rate

66.7%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(1)

Terminated(2)

Detailed Status

Terminated2

Recruiting1

Completed1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

33.3%

Most Advanced

Phase 2

Trials by Phase

Phase 11 (33.3%)

Phase 21 (33.3%)

N/A1 (33.3%)

Trials by Status

recruiting125%

completed125%

terminated250%

Recent Activity

1 active trials

Showing 4 of 4

recruiting

Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear

NCT03909139

terminatednot_applicable

Evaluation of the Single Injection of BMAC vs HA in the Treatment of the Ankle Osteoarthritis

NCT04883892

completedphase_2

Retrograde Application of Bone Marrow Aspirate Concentrate

NCT03372954

terminatedphase_1

Feasibility Study of BMAC Enhanced CABG

NCT01074099

Clinical Trials (4)

Showing 4 of 4 trials

NCT03909139

Use of BMAC With Hip Arthroscopy Treatment of FAI and Labral Tear

Recruiting

NCT04883892Not Applicable

Evaluation of the Single Injection of BMAC vs HA in the Treatment of the Ankle Osteoarthritis

Terminated

NCT03372954Phase 2

Retrograde Application of Bone Marrow Aspirate Concentrate

Completed

NCT01074099Phase 1

Feasibility Study of BMAC Enhanced CABG

Terminated

All 4 trials loaded

Drug Details

Intervention Type: BIOLOGICAL
Total Trials: 4